NMPA Approval

Ephedrine Hydrochloride and Diphenhydramine Hydrochloride Tablets

Approval Number

国药准字H41025501

Company许昌未来制药有限责任公司

Registration Date

March 15, 2023

Drug Information

Generic Name

麻黄碱苯海拉明片

Dosage Form

片剂

Strength

盐酸麻黄碱25mg，盐酸苯海拉明25mg。

Drug Type

化学药品

Registration Date

March 15, 2023

Company Information

Applicant Company

Company Name许昌未来制药有限责任公司

Company Address

许昌市东城区许由东路3888号

Manufacturing Company

Company Name许昌未来制药有限责任公司

Company Address

许昌市东城区许由东路3888号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

麻黄碱苯海拉明片 - NMPA 批准文号 | MedPath